Detection of Human Cytomegalovirus in Different Histopathological Types of Glioma in Iraqi Patients

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr class="thead"><td align="left" rowspan="2">
                HCMV proteins<br/>Number = 36</td><td align="center" rowspan="2">
                
                Positivity<br/> Number (%)</td><td align="center" colspan="4">Grading of positive sections</td></tr><tr class="thead"><td align="center">Grade 1<br/>Number (%)</td><td align="center">Grade 2<br/>Number (%)</td><td align="center">Grade 3<br/>Number (%)</td><td align="center">Grade 4<br/>Number (%)</td></tr><tr><td class="thead-hr" colspan="6"><hr/></td></tr><tr><td align="left">IE1-72</td><td align="center">33 (91.67)</td><td align="center">7 (21.21%)</td><td align="center">6 (18.18)</td><td align="center">7 (21.21)</td><td align="center">13 (39.39)</td></tr><tr><td align="left">pp65</td><td align="center">28 (77.78)</td><td align="center">7 (25)</td><td align="center">9 (32.14)</td><td align="center">7 (25)</td><td align="center">5 (17.58)</td></tr><tr><td align="left">Late antigen</td><td align="center">26 (72.22)</td><td align="center">7 (26.92)</td><td align="center">10 (38.46)</td><td align="center">8 (30.77)</td><td align="center">3 (11.54)</td></tr><tr class="table-tr"><td colspan="6"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td>
              Percentage changes and grading in early, mid, and late antigen HCMV protein in glioblastoma multiforme patients. The grade number and percentage (%) were calculated in a blinded fashion. The number and % of positive patients are indicated for each antigen.<br/></td></tr></table>

The percentage and grading of HCMV protein in GBM.

BioMed Research International

tab1

Table 1

Table 1: Detection of Human Cytomegalovirus in Different Histopathological Types of Glioma in Iraqi Patients 